Wells Fargo analyst Larry Biegelsen reiterated an Overweight rating and $107.00 price target on Abbott Labs (NYSE: ABT) ahead of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE